Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

KeyBanc analyst Paul Knight maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

Q4 2024 Earnings Conference Call February 14, 2025 9:00 AM ETCompany ParticipantsRebecca Morley - Vice President, ...

Darcy Reese; Vice President - AEP Investor Relations; American Electric Power Company Inc William Fehrman; President and Chief Executive Officer; American Electric Power Company Inc Trevor Mihalik; ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 21,829.91 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.